Abu-Zaid, M. H. et al. African guidelines for diagnosis and management of polyarticular juvenile idiopathic arthritis: PAFLAR initiative. Pediatr. Rheumatol. 23, 27 (2025).
Migowa, A. N. et al. Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry. Pediatr. Rheumatol. 22, 67 (2024).
Albuquerque, C. P. et al. Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicentre observational study. Adv. Rheumatol. 63, 17 (2023).
Galal, S. Population of Africa in 2021, by age group. https://go.nature.com/3GIxGjL (2024).
Vilaiyuk, S. et al. The inequity of global healthcare in pediatric rheumatology. Best Pract. Res. Clin. Rheumatol. 38, 101983 (2024).
Naddei, R. et al. Clinical insights into heterogeneity of rheumatoid factor negative polyarticular juvenile idiopathic arthritis across the world. Pediatr. Rheumatol. 23, 30 (2025).
Chatterjee, R. et al. Serious infections and tuberculosis adversely impact outcomes of juvenile onset systemic lupus erythematosus in India. Lupus 34, 193–203 (2025).
Article CAS PubMed Google Scholar
Silverman, E. et al. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 52, 554–562 (2005).
Article CAS PubMed Google Scholar
Vermeer, E. et al. Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature. Curr Rheumatol. Rep. 25, 276–284 (2023).
Article CAS PubMed PubMed Central Google Scholar
Abu-Zaid, M. H., Adebajo, A. & El Miedany, Y. Potential for biosimilars in rheumatology in Africa. Ann. Rheum. Dis. 82, 1508–1510 (2023).
Comments (0)